Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sherman

Showing results (741-750 of 825) with videos related to

Pageof 83
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Lancet Regional Health. Americas|January 19, 2026
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control studyCaineng Cao, Teeradon Treechairusame, Amir H Safavi, et al.
Gut|May 16, 2002
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposisR K S Phillips, M H Wallace, P M Lynch, et al.
Contemporary Clinical Trials|March 7, 2013
Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experienceBarbara Sternfeld, Andrea LaCroix, Bette J Caan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid CancersJena D French, Bryan R Haugen, Francis P Worden, et al.
Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.
Head & Neck|March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinomaMatthew G Fury, Han Xiao, Eric J Sherman, et al.
Lancet (London, England)|September 15, 1999
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialL A Guay, P Musoke, T Fleming, et al.
Journal of Clinical Medicine|December 11, 2025
Concomitant Surgical Ablation Using a Novel Bipolar Radiofrequency Clamp: Outcomes from the TRAC-AF RegistryChristian Shults, Armin Kiankhooy, Shaf B Holden, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Pageof 83

Showing results (741-750 of 825) with videos related to

Sort By:
Pageof 83
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2016
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinomaA L Ho, L Dunn, E J Sherman, et al.
Lancet Regional Health. Americas|January 19, 2026
Intensity-modulated proton therapy vs intensity-modulated radiotherapy in nasopharyngeal carcinoma: a case-control studyCaineng Cao, Teeradon Treechairusame, Amir H Safavi, et al.
Gut|May 16, 2002
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposisR K S Phillips, M H Wallace, P M Lynch, et al.
Contemporary Clinical Trials|March 7, 2013
Design and methods of a multi-site, multi-behavioral treatment trial for menopausal symptoms: the MsFLASH experienceBarbara Sternfeld, Andrea LaCroix, Bette J Caan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2024
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid CancersJena D French, Bryan R Haugen, Francis P Worden, et al.
Cancer Discovery|February 8, 2020
Pan-Cancer Efficacy of Vemurafenib in <i>BRAF</i> <sup>V600</sup>-Mutant Non-Melanoma CancersVivek Subbiah, Igor Puzanov, Jean-Yves Blay, et al.
Head & Neck|March 19, 2015
Phase II trial of bevacizumab + cetuximab + cisplatin with concurrent intensity-modulated radiation therapy for patients with stage III/IVB head and neck squamous cell carcinomaMatthew G Fury, Han Xiao, Eric J Sherman, et al.
Lancet (London, England)|September 15, 1999
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialL A Guay, P Musoke, T Fleming, et al.
Journal of Clinical Medicine|December 11, 2025
Concomitant Surgical Ablation Using a Novel Bipolar Radiofrequency Clamp: Outcomes from the TRAC-AF RegistryChristian Shults, Armin Kiankhooy, Shaf B Holden, et al.
Experimental Neurology|July 28, 2020
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesiaMitchell J Bartlett, Andrew J Flores, Tony Ye, et al.
Pageof 83